Processa Pharmaceuticals, Inc. Purchase Agreements
8 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on January 22, 2024)
- Form of Securities Purchase Agreement, dated February 9, 2023, by and between Processa Pharmaceuticals, Inc. and each of the Investors (as defined therein) (Filed With SEC on February 13, 2023)
- Purchase Agreement, dated March 23, 2022, between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 24, 2022)
- Securities Purchase Agreement dated February 16, 2021 (Filed With SEC on February 18, 2021)
- Amendment to License Agreement and Securities Purchase Agreement with CoNCERT Pharmaceuticals (Filed With SEC on September 17, 2020)
- Asset Purchase Agreement. Dated October 2, 2017, among the Company, Promet Therapeutics LLC and Processa Therapeutics LLC (Filed With SEC on September 17, 2020)
- Form of Purchase Agreement (Filed With SEC on May 21, 2018)
- Amendment to License Agreement and Securities Purchase Agreement with CoNCERT Pharmaceuticals (Filed With SEC on April 16, 2018)
